Gender-Based Screening for Chlamydial Infection and Divergent Infection Trends in Men and Women by Rogers, Susan M. et al.
Gender-Based Screening for Chlamydial Infection and
Divergent Infection Trends in Men and Women
Susan M. Rogers1*, Charles F. Turner2, William C. Miller3, Emily Erbelding4¤, Elizabeth Eggleston1,
Sylvia Tan1, Anthony Roman5, Marcia Hobbs3, James Chromy6, Ravikiran Muvva7,
Laxminarayana Ganapathi8
1 Statistics and Epidemiology Division, Research Triangle Institute, Washington D.C., United States of America, 2 Queens College and the Graduate Center, City University
of New York, Flushing, New York, United States of America, 3 School of Medicine, University of North Carolina, Chapel Hill, North Carolina, United States of America,
4 School of Medicine, Johns Hopkins University, Baltimore, Maryland, United States of America, 5 Center for Survey Research, University of Massachusetts at Boston,
Boston, Massachusetts, United States of America, 6 Statistics and Epidemiology Division, Research Triangle Institute, Research Triangle Park, North Carolina, United States
of America, 7 Baltimore City Department of Health, Bureau of STI/HIV Prevention, Baltimore, Maryland, United States of America, 8 Research Computing Division, Research
Triangle Institute, Research Triangle Park, North Carolina, United States of America
Abstract
Objectives: To assess the potential impact of chlamydial screening policy that recommends routine screening of women
but not men.
Methods: Population surveys of probability samples of Baltimore adults aged 18 to 35 years in 1997–1998 and 2006–2009
collected biospecimens to estimate trends in undiagnosed chlamydial infection. Survey estimates are compared to
surveillance data on diagnosed chlamydial infections reported to the Health Department.
Results: Prevalence of undiagnosed chlamydial infection among men increased from 1.6% to 4.0%, but it declined from
4.3% to 3.1% among women (p = 0.028 for test of interaction). The annual (average) number of diagnosed infections was
substantially higher among women than men in both time periods and increased among both men and women.
Undiagnosed infection prevalence was substantially higher among black than non-black adults (4.0% vs 1.2%, p = 0.042 in
1997–98 and 5.5% vs 0.7%, p,0.001 in 2006–09).
Conclusion: Divergent trends in undiagnosed chlamydial infection by gender parallel divergent screening recommenda-
tions that encourage chlamydial testing for women but not for men.
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Introduction
Untreated Chlamydia trachomatis infection increases the risk of
pelvic inflammatory disease, chronic pelvic pain, and ectopic
pregnancy in women [1]. Complications in men are rare, but
untreated infection can lead to subsequent infection and morbidity
in their female sexual partners. Repeat chlamydial infections are
common in women [2–3] increasing their risk of serious
reproductive problems.
Both the U.S. Preventive Services Task Force (USPSTF) [4]
and the Centers for Disease Control and Prevention (CDC) [5]
recommend chlamydial screening for sexually active women under
25 years of age (the CDC recommendation includes women
through age 25) plus older women who are thought to be at
increased risk based on their previous sexually transmitted
infection history or patterns of sexual activity. This recommenda-
tion follows from the USPSTF conclusion that there is good
evidence that screening for chlamydial infection in women who
are at increased risk can reduce the incidence of PID [Pelvic
Inflammatory Disease]. Routine screening of men is not recom-
mended.
The impact of these divergent screening recommendations is
not well understood, but ‘‘asymptomatic, untreated infections in
men provide a reservoir of infection that may make it difficult to
improve health outcomes in women’’ [USPSTF, p.130]. While
concluding that the direct benefit to men of screening was likely to
be small, the USPSTF noted that ‘‘screening for chlamydial
infection in men may be beneficial if it were to lead to a decreased
incidence of chlamydial infection in women. The USPSTF did
not, however, find evidence to support this outcome … and
identified this as a critical gap in the evidence’’ [4].
PLOS ONE | www.plosone.org 1 February 2014 | Volume 9 | Issue 2 | e89035
Several epidemiological trends could be expected to arise from
the current gender-based screening policy. First, one would expect
the number of chlamydial infections diagnosed and treated to rise
substantially for females but not for males. Second, the prevalence
of undiagnosed asymptomatic infections among men should be largely
unaffected given the lack of male screening. Finally, one might
expect the prevalence of undiagnosed infection in females to decline
over time, but the extent of that decline might be limited by the
undiminished prevalence of infection among their male partners.
Nonetheless the USPSTF recommended that public health efforts
focus on increasing screening for women for whom the direct
benefits were most certain.
In this paper, we present evidence of the potential impact of this
policy over the period 1997–98 through 2006–2009 in Baltimore,
MD. Chlamydial infection became a reportable STI in Maryland
in 1994 [5] and Baltimore has one of the highest reported rates of
infection among U.S. cities [6]. We report surveillance data of
diagnosed infections reported to the Baltimore City Health
Department (BCHD) in 1998 and 2006–09. We also report results
of population surveys of undiagnosed chlamydial infection conducted
in 1997–98 and 2006–09 among probability samples of young
Baltimore adults (Baltimore STD and Behavior Survey (BSBS) and
Monitoring STDs Survey Program (MSSP)) [7–8].
By comparing surveillance counts of diagnosed chlamydial
infection with survey estimates of prevalent undiagnosed infection
during the same time period we provide a concise account of the
epidemiology of chlamydial infection in an urban population over
time. This methodology provides evidence – albeit imperfect – for
evaluation of the relative effectiveness in a single community of
public health efforts to diagnose and treat chlamydial infection
that focus exclusively on women.
Methods
Overview
This article reports chlamydia results from two population-
based surveys fielded by this article’s primary authors. The first
survey, the Baltimore STD and Behavior Survey (BSBS), was
fielded in 1997–98. STI prevalence estimates from this survey of
Baltimore adults ages 18 to 35 were published in 2002 in the
Journal of the American Medical Association [7]. The second survey, the
Monitoring STIs Survey Program (MSSP), was fielded in 2006–
2009. Chlamydia results from the second survey of Baltimore
residents ages 15 to 35 year olds were published in 2011 in Sexually
Transmitted Diseases [8]. To assess changes in chlamydia prevalence
over the period 1997–98 to 2006–09, the present article combines
the BSBS and MSSP datasets and restricts this composite sample
to Baltimore residents ages 18 to 35.
Additional discussion of research methods can be found in Text
S1.
Trends in Diagnosed Chlamydial Infection
Cases of diagnosed chlamydial infection among 18 to 35 year
olds reported by physicians and laboratories to the BCHD were
tabulated by gender and age in 1998 (reported previously) [7] and
2006 through 2009 (tabulated by R Muvva). For the survey period
September 2006 through June 2009, reported cases were summed
and an annual average case count (based on the 33-month survey
period) was derived. Percentages for population case rates were
calculated using 1998 Census estimates of the number of
Baltimore residents aged 18 to 35 years as the denominator; for
2006–09 the average annual population size was used (see Text S2
and Text S3 and Table S1).
Trends in Undiagnosed Chlamydial Infections
Population Surveys: 1997–98 BSBS and 2006–09 MSSP. Estimates
of trends in the prevalence of undiagnosed chlamydial infections
were obtained from our population surveys of probability samples
of the Baltimore population in 1997–98 and 2006–09. These
surveys were designed specifically to provide estimates of and
trends in the population prevalence of sexually transmitted
infections among young adults in Baltimore, Maryland. The
Baltimore STD and Behavior Survey (BSBS) used in-person
household interviews with urine-based testing for C. trachomatis to
Figure 1. Reports of Diagnosed Chlamydial Infections (1a) and Estimates of Prevalent Undiagnosed Chlamydial Infections (1b) by
Gender and Year among Baltimore adults, ages 18 to 35. See Text S2 for additional information.
doi:10.1371/journal.pone.0089035.g001
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assess infection prevalence among 18 to 35 year olds between
January 1997 and September 1998. Details of the BSBS sample
design and survey execution were published previously7. The
2006–09 Monitoring STIs Survey Program (MSSP) used tele-
phone audio computer-assisted self-interviewing (T-ACASI) tech-
nology [9–12] and biospecimen collection kits sent out and
returned by US mail to diagnose chlamydial infection among
Baltimore residents aged 15 to 35 years between September 2006
and June 2009. We restricted our analyses to ages 18 to 35 in both
surveys.
Our decision to screen adults through the age of 35 in the 1997–
98 BSBS was motivated by the lack of information on the
population prevalence of chlamydial infections in the Baltimore
population. Investigators thought it might be possible to detect
hidden pockets of undiagnosed infection in unsuspected segments
of the Baltimore population. The 2006–09 MSSP maintained a
top age of 35 because that survey included testing for Trichimonas
vaginalis which is prevalent in women ages 30 to 49 [13].
Sampling and sample weighting. The sample for the
1997–98 BSBS was drawn from households selected from the
Baltimore Real Estate Property Registry. Two sample strata were
oversampled: (1) black men and (2) adults living in predominantly
white census tracts with high levels of reported sexually
transmitted infections to enhance the precision of estimates for
these subgroups.
For the 2006–09 MSSP, our target population was young adults
residing in Baltimore households with landline telephones. Over
the course of the MSSP survey (September 2006 through June
2009), we estimate that approximately 15% of Baltimore
households did not have a landline telephone (see Text S4). Four
strata were sampled probabilistically. The first three strata were
sampled using commercially-available, regularly updated infor-
mation on Baltimore households and included households with a
landline telephone (1) that were believed to contain someone aged
15–35 years, (2) that were believed to have no one aged 15–35
years, and (3) whose residents were of unknown age. A fourth
stratum was constructed by selecting all known landline telephone
numbers in Baltimore and removing numbers that appeared on
the commercial list to ensure that each telephone number was in
one and only one stratum.
Sample weights were derived for both surveys to adjust for the
unequal probabilities of selection based on the sample design and
Table 1. Sociodemographic characteristics of Baltimore survey respondents providing specimens for chlamydial testing in 1997–
98 and 2006–2009.
1997 – 1998 (a) 2006 – 2009 (b)
Characteristic Unweighted N % (95% CI) Unweighted N % (95% CI) P
Sample N 579 100.0 na 1766 100.0 na
Gender
Female 335 52.0 (46.7, 57.2) 1148 54.7 (51.7, 57.7) 0.378
Male 244 48.0 (42.8, 53.3) 618 45.3 (42.3, 48.3)
Race (c)
Black (not Hispanic) 316 65.4 (61.3, 69.3) 1046 58.4 (55.5, 61.2) 0.006
Non-Black (incl. Hispanic) 263 34.6 (30.8, 38.7) 719 41.6 (38.8, 44.5)
Age
18–19 48 10.3 (7.4, 14.1) 222 14.4 (12.4, 16.7) 0.059
20–24 138 24.9 (20.6, 29.6) 460 27.9 (25.3, 30.7)
25–29 160 27.6 (23.2, 32.5) 501 26.6 (24.1, 29.3)
30–35 233 37.2 (32.4, 42.4) 583 31.0 (28.4, 33.8)
Marital status
Married 123 21.1 (17.3, 25.5) 378 22.1 (19.8, 24.6) ,0.001
Cohabiting, not married 80 15.6 (12.2, 19.8) 375 24.7 (22.2, 27.4)
Widow, divorced, separated 71 9.7 (7.2, 12.8) 61 3.0 (2.2, 4.1)
Never married 305 53.6 (48.4, 58.7) 951 50.3 (47.3, 53.2)
Education
Less than high school 146 22.1 (18.4, 26.4) 280 17.0 (14.9, 19.4) ,0.001
High school graduate 183 36.6 (31.5, 42.1) 496 31.7 (28.9, 34.6)
Some college/trade school 158 27.8 (23.4, 32.6) 475 26.5 (24.0, 29.2)
College graduate 90 13.5 (10.6, 17.0) 514 24.8 (22.5, 27.3)
Notes: Results for adults ages 18 to 35 from the Baltimore STD and Behavior Survey (BSBS) and the Monitoring STIs Survey Program (MSSP). Table shows unweighted
base Ns for percentages and weighted estimates of the percentage of the survey respondents with sociodemographic characteristic. Weighted estimates account for
differing probabilities of selection and post-stratification adjustment to match Census marginal for Baltimore, Maryland. 95% confidence intervals (CI) were calculated
using statistical algorithms that take account of the complex sample designs of the surveys. Table excludes all respondents who were missing a chlamydia test result.
(a) The BSBS survey was conducted between January 1997 and September 1998.
(b) The MSSP survey was conducted between September 2006 and June 2009. Mailed urine specimens were received by the laboratory through August 2009.
(c) Persons who identified themselves as Hispanic are classified as Non-Black for both BSBS and MSSP analyses. This differs from our previous analysis of the BSBS in
which persons were assigned to their chosen racial category; Hispanic origin was ignored. Of the 20 BSBS respondents who claimed Hispanic origin, 11 identified their
race as ‘‘Other’’ and 2 selected ‘‘American Indian or Alaskan Native’’ as their racial category.
doi:10.1371/journal.pone.0089035.t001
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for specimen nonresponse. Details of sample weighting procedures
are provided in Text S5).
Interview/specimen collection. Respondents in both sur-
veys completed detailed computerized behavioral questionnaires.
Upon interview completion, respondents provided a biospecimen
for chlamydial testing (see Text S6). Specimens were tested using a
ligase chain reaction assay (LCx, Abbott Laboratories) in the BSBS
and transcription-mediated amplification (APTIMA Combo2,
Gen-Probe, Inc) in MSSP. Both tests demonstrate high sensitivity
and specificity when used as screening tests for chlamydial
infection [14]. To minimize the possibility of false positive results
within our non-clinical population, all positive specimens were
retested [15–16]. Chlamydial infection was defined as a repeatedly
positive test result.
Ethics Statement
All participants in the 1997–98 BSBS were adults. Interviews
and specimen collection were conducted in the household and
participants provided written consent for both the survey data
collection and for the urine collection and STD testing. Adult
participants in the 2006–09 MSSP telephone survey provided
verbal consent. Minors aged 15 to 17 years in the MSSP were also
recruited, and they provided verbal consent with parental/
guardian permission and minor assent for the telephone survey.
Parents were informed that their child’s survey and STI test results
were confidential and that they would not be shared with parents.
Verbal consent was used for the telephone survey portion of the
MSSP because there is no face-to-face contact in a telephone
survey. Verbal consent is the widely-accepted norm for obtaining
consent in telephone surveys. (Further details of the MSSP survey
consent procedures are provided in Text S7.) Written consent was
obtained for the mailed STI specimen collection portion of the
MSSP. Respondents who agreed to provide a specimen for STI
testing were mailed a collection kit (a maximum of three days after
the T-ACASI interview) with instructions and a written consent
form. Only specimens submitted to the laboratory with a signed
consent form were tested.
All study procedures - including the foregoing consent
procedures – were approved by the Institutional Review Boards
(IRBs) of the Research Triangle Institute (BSBS and MSSP), the
University of North Carolina at Chapel Hill (MSSP), the
University of Massachusetts at Boston (MSSP), and the Johns
Hopkins Medical Institutions (BSBS and MSSP).
Data Access
The data required to replicate our substantive analyses will be
available to authorized researchers under a restricted data use
agreement with the Inter-University Consortium for Political and
Social Research (ICPSR) at the University of Michigan. Because
of the sensitive nature of these data and the risk of deductive
disclosure of respondents’ identity, researchers must agree to the
ICPSR’s terms of use which require, in part, compliance with the
repository’s access regulations and codes of scientific conduct.
Statistical Analyses
Our analysis of diagnosed infections is derived from a census of all
infections reported by laboratories and health care providers to the
Health Department (see Text S2). Our statistical analyses of the
estimated prevalence of undiagnosed infections use survey data from
respondents who provided biospecimens for chlamydial infection
testing. We tabulated frequencies of demographic characteristics
to obtain descriptive profiles of the survey samples and to control
for differences in sample composition across the two survey
periods. Survey estimates of infection prevalence were derived
using sample weights and tabulated by gender, age, and race/
ethnicity. Tests of the equivalence of prevalence estimates among
population subgroups across the two survey periods (2006–09
versus 1997–98) were derived using crude and adjusted odds
ratios. Adjusted odds ratios were calculated using logistic
regression models to adjust for the effects of gender, race/
ethnicity, age, education, and marital status on chlamydial
infection. All statistical analyses accounted for the complex survey
design using the svy algorithms of Stata, versions 10–12 [17–18].
Assessment of impact of missing data. To assess the
impact of biospecimen collection non-response on survey estimates
of infection prevalence, we previously used logistic regression to
model the likelihood that the respondents would test positive based
on sociodemographic, behavioral, and health-related variables.
Our BSBS analyses suggested that prevalence estimates were
robust in the face of missing urine specimens [7]. This result is
consistent with findings from the 1995 National Survey of
Adolescent Males (NSAM) and the National Longitudinal Study
of Adolescent Health (Add Health, Wave 3). Biospecimens were
missing for 12% to 28% of participants in these surveys, but
multiple imputation (NSAM) and sensitivity analyses (Add Health)
suggest that the impact of this biospecimen nonresponse on
prevalence estimates was not likely to be substantial [19–20].
For the present article, we carried out parallel analyses using
both single imputation logistic models and multiple imputation
models using chained equations (MICE, see Text S8). The
synthetic estimate of chlamydia prevalence derived from our single
imputation modeling for missing MSSP biospecimens was 3.58%
which was nearly identical to the estimate (3.54%) derived from
tested specimens alone. MICE models were restricted to the black
population since there were few infections that could be used to
estimate MICE models for the nonblack population (0 among
nonblack females in 1997–98 and 3 in 2006–09; 4 among
nonblack males in 1997–98 and 1 in 2006–09). We used the
MICE imputation procedures of Stata v12 to impute the
substantial number of missing chlamydial infection tests (n = 493
of 1,856 black respondents) plus a small number of missing
observations for some demographic variables. Predictor variables
used in MICE imputations included age, education, married (or
not), number of sex partners in past year, gonorrhea and
chlamydia diagnoses in past year, dysuria and discharge in past
two (BSBS) or three (MSSP) months, male gender, time period
(1997–98 vs. 2006–09), interaction of male-by-time period,
interaction of gender-by time period, sample strata, and sample
weight. Logit models were used for all imputations except
education and number of sex partners in past year. Imputation
of these variables used ordered logit models. The chained equation
multiple imputation procedure generated 60 sets of imputed data
after a burn-in period of 100 iterations. Our hypothesis testing
using MICE data took account of the complex sample designs of
our population surveys using Stata’s svy estimation command.
Sensitivity analyses of assay performance. Sensitivity
analyses were conducted to assess the impact of diagnostic test
performance on prevalence estimates using a range of plausible
estimates for the sensitivity (low = 0.869, high = 0.94) and speci-
ficity (low = 0.992, high = 0.999) of the assays used in each survey
[14]. Tabulations examined the combination of effects from low
(sensitivity = 0.869, specificity = 0.992) to high estimates of test
performance (sensitivity = 0.94, specificity = 0.999) for the overall
population and gender and racial subgroups.
Chlamydial Sceening in U.S. Men and Women
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Results
Trends in Diagnosed Chlamydial Infections
Figure 1a provides the annual number of chlamydial infections
diagnosed among Baltimore men and women ages 18 to 35.
Among men, the number of diagnosed infections was 391 in 1998,
and it increased to 878 per year in 2006–09. Annual diagnosed
infections were substantially higher among women and the
average annual number of infections diagnosed among women
increased from 3,255 in 1998 to 4,475 in 2006–09.
Trends in Undiagnosed Chlamydial Infections
Survey estimates of infection prevalence. Of the 3182
households selected for interview in the 1997–98 BSBS, 86%
(2727) were successfully screened. 1224 eligible adults (aged 18 to
45 years) were identified and 1014 (82.8%) completed an
interview. Of the 728 BSBS survey respondents aged 18 to 35
years, 579 (79.5%) provided a specimen adequate for testing.
In the 2006–09 MSSP, 73,318 telephone numbers were
released over the survey period. 48,136 (65.6%) of these numbers
were non-residential (out of service, businesses, faxes, etc.), 20,435
(27.9%) were residential, and the status of 4747 (6.5%) numbers
was undetermined after repeated attempts. Of the residential
numbers, 14,199 (69.5%) were screened and 4314 included one or
more eligible household members aged 18 to 35 years. Interviews
were completed with a randomly-selected 18 to 35 year-old from
2471 (57.3%) of those households; 1766 of these survey
respondents (71.5%) mailed in specimens for testing.
Women were more likely to participate than men (as reflected
by larger unweighted sample Ns, Table 1). Respondents in the
2006–09 MSSP were more likely to be non-Black, to report
cohabiting with a partner, and to have graduated from college
than respondents in the 1997–98 BSBS. While some of these
differences are consistent with demographic change, e.g., college
graduation rates among Baltimore women ages 18 to 34 years
increased from 16.2% in 2000 to 27.8% in 2008 [20] other
discrepancies may reflect the impact of differing survey method-
ologies. The impact of these differences cannot be precisely
calibrated. Statistical controls are included to adjust for survey
variation in sociodemographic composition across the two time
periods. All adjusted ORs were calculated in logit regressions that
included the following control variables: age in years, education,
marital status. Adjusted ORs for comparisons within race
categories included an additional control for gender. Adjusted
ORs for comparisons within genders included an additional
control for race (black vs. non-black). Calculation of the adjusted
OR for the total population included controls for both gender and
race.
Trends in Overall Prevalence
The estimated prevalence of undiagnosed chlamydial infection
rose insignificantly from 3.0% (95% CI 1.7, 5.2) in 1997–98 to
3.5% (95% CI 2.6, 4.8) in 2006–09 (adjusted OR = 1.09, p.0.5;
Table 2). Estimated prevalence was significantly higher among
women (4.3%, 95% CI 2.2, 8.4) than men (1.6%, 95% CI 0.7, 3.4)
in 1997–98 (p = 0.047). By 2006–09 the estimated prevalence was
lower among women than among men (3.1% versus 4.0%), but the
difference was not statistically significant (p = 0.414). In both
survey periods, the prevalence of infection was substantially higher
among non-Hispanic blacks than among other adults (4.0% vs.
1.2%, p = 0.042 in 1997–98 and 5.5% vs. 0.7%, p,0.001 in 2006–
09).
Sensitivity analyses of potential impact of test
performance. Assuming a range of plausible values for
diagnostic assay sensitivity and specificity, our sensitivity analyses
indicate that the overall prevalence would range from 2.4% to
3.3% in the BSBS and from 2.9% to 3.8% in the MSSP. These
estimates compare favorably with our population prevalence
estimates.
Variation in Estimated Trends by Gender and Race
Trends in the estimated prevalence of undiagnosed chlamydial
infection varied substantially for men and women (Figure 1b and
Table 2). Among men, estimated prevalence increased from 1.6%
to 4.0% between 1997–98 and 2006–09 (adjusted OR = 2.5, 95%
CI 0.9, 6.6; p = 0.08) whereas among women a decline in
prevalence from 4.3% to 3.1% was observed over the same time
period (adjusted OR = 0.7, 95% CI 0.3, 1.6; p = 0.33). An
interaction test for non-equivalence of the estimated trends by
gender was statistically significant (p = 0.028, test incorporates
adjustment for differences in sociodemographic composition of
samples).
We explored the possibility that the observed increase in
infection prevalence among males in 2006–09 might be related to
an increase in asymptomatic infection among men who have sex
with men (MSM). Further analyses of the MSSP data indicate that
this is not the case (see Text S9).
The divergence in trends by gender was particularly striking for
black adults. Seven percent (95% CI = 4.2, 11.4) of black men had
an undiagnosed chlamydial infection in 2006–09 compared to
1.1% (95% CI = 0.3, 3.6) in 1997–98 (adjusted OR = 5.0, 95% CI
1.3, 18.6, p = 0.02). In contrast, among black women, the
prevalence of infection was insignificantly lower in 2006–09 than
in 1997–98 (adjusted OR = 0.6, 95% CI 0.2, 1.4, p = 0.23). An
interaction test for non-equivalence of the estimated trends in
prevalence of undiagnosed CT infection among black respondents
by gender was statistically significant (p = 0.005). Parallel inferenc-
es are obtained when analyses use MICE procedures to impute
missing observations (see Text S8 and Table S2). Using MICE-
imputed data, we find a statistically significant (p = 0.049) increase
in the estimated prevalence of undiagnosed chlamydial infection
among black males from 1.6% (se = 1.6%) to 7.2% (se = 1.8%)
while there is no significant change (p = 0.49) in estimated
prevalence among black females. A test of the gender by time period
by prevalence interaction using MICE data (p = 0.034) suggests that
trends over the time period 1997–98 to 2006–09 in infection
prevalence were significantly different for black males and black
females.
Variation in Estimated Trends by Age
Among both women and men, the estimated prevalence of
undiagnosed chlamydial infections was significantly lower among
older adults (see Text S10 and Figure S1). As shown in Figures 2a
and 2b, trends over time in infection prevalence varied by gender
and age group. Figure 2b suggests that the prevalence of
undiagnosed infection declined for the group for whom routine
chlamydial screening is recommended –18–24 year old females.
Estimated prevalence for this group declined from 9.4% (CI: 4.2–
19.9) in 1997–98 to 4.4% (CI: 2.7–7.1) in 2006–09. However, this
trend over time is not statistically significant (OR = 0.44, p = 0.11).
In contrast, the estimated prevalence of undiagnosed chlamydial
infections among 18 to 24 year old males (Figure 2a) trends in the
opposite direction. It rises from 2.1% (CI: 0.7–6.0) in 1997–98 to
9.4% (CI: 5.6–15.4 in 2006–09). This increase in estimated
prevalence is statistically significant (OR = 4.9, p = 0.01). Addi-
tional details of the analyses of age and infection prevalence are
shown in Text S10 and Table S3).
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Discussion
Over the period 1997–98 to 2006–09, the overall burden of
diagnosed chlamydial infection increased in Baltimore, primarily
due to increased reports of diagnosed infection among women.
The annual number of diagnosed chlamydial infections in women
substantially exceeded that for men in each time period. While our
population estimates suggest that the prevalence of undiagnosed
infection among women remained relatively stable, substantial and
unexpected increases in undiagnosed infections were observed
among men, particularly young men less than 25 years of age. The
divergence between men and women in these results is most
pronounced among young black adults.
These results may be a direct consequence of current screening
policies that encourage chlamydial testing and treatment among
sexually active young females but not males. While current
screening policy may have enhanced reporting of diagnosed
infections and stabilized or slightly reduced the prevalence of
undiagnosed infection among women, a growing reservoir of
infection persists among young men in Baltimore. We suspect that
reducing chlamydial infection and its associated morbidity may
require policies that drain this reservoir of asymptomatic infection
in the population from which most young women acquire their
sexual partners, i.e., young men. These policies might include
aggressive outreach to and treatment of recent sexual partners
including presumptive treatment, repeat screening of positive cases
following treatment, and community-based screening programs in
high-prevalence locales.
A positive impact of screening on the prevalence of chlamydial
infection has been difficult to demonstrate with confidence at the
national and state levels. Reported cases reflect a mixture of
incident infections treated due to symptoms and asymptomatic
cases treated secondary to screening. Greater screening leads to
more infections identified, and rates may actually increase over the
short-term. At the national level, the prevalence of undiagnosed
chlamydial infection appears to have decreased based on
population data from NHANES [22] and the National Job
Training Program [23]. In NHANES, the prevalence reportedly
decreased by 53% in men and 31% in women aged 14–39 years
over the period 1999–2008, however decreases in women aged 14
to 25 years, the age population targeted for annual screening, were
not observed (19% overall reduction, 95% CI, 257, 57, p = 0.54)
nor did overall prevalence among non-Hispanic black men and
women change across the survey periods (0% overall reduction,
95% CI 237, 52). It is possible that statistical power was limited to
reliably detect effects across time among subpopulations due to
low disease prevalence and small sample sizes [24]. Nonetheless,
national estimates, in conjunction with more precise estimates
from well-designed and well-populated local probability samples,
can be particularly informative for evaluating screening policy.
Chlamydia epidemics and their control are inherently local
phenomena. The formation of sexual partnerships benefits from and
sex itself requires geographic propinquity. Thus sexual networks
tend to be geographically constrained, and the number and types
of sexual partners available in different locales – as well as the
prevalence of undiagnosed infection – may vary substantially
across locales. Past research mapping the geography of sexual
partnerships in Baltimore has demonstrated that there is a strong
tendency for both STD clinic patients [25] and adults [26] in
general to form sexual partnerships that are spatially assortative
(See Text S11).
The ubiquity and intensity of local screening and treatment
programs may also vary substantially reflecting variation in explicit
policies, Health Department resources, zeal of staff and policy-
makers, and the perceived ‘‘seriousness’’ of STI problems. Because
of variation in these factors, the benefits and cost-effectiveness of
screening are more likely to be directly evidenced within a specific
locale rather than nationwide. Our results, focused on the city of
Baltimore, provide important evidence suggesting the limited
impact of screening in that city. We believe that repetition of this
research in other locales is warranted.
The inadequacy of screening strategies that focus exclusively on
females is illustrated by studies that have intensively monitored
young women. Batteiger and colleagues [2] followed 210
adolescent females treated for chlamydial infection for 3 years.
Despite screening and assessments at 3-month intervals, 121
women had subsequent chlamydial infections following treatment.
Based on genotyping results, 84% of these repeat infections were
attributable to reinfection. Without screening and treatment of
Figure 2. Estimated prevalence of undiagnosed chlamydial infection by age, survey year, and gender. (Source: 1997–98 Baltimore STD
and Behavior Survey and 2006–09 Monitoring STIs Survey Program).
doi:10.1371/journal.pone.0089035.g002
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male partners, even an intensive regimen of chlamydial screening
and treatment for women yielded disappointing results.
The availability of highly sensitive and specific urine-based
nucleic acid amplification tests has facilitated the detection and
treatment of asymptomatic infections among men. Public health
authorities should consider routine screening of accessible popula-
tions of young men in locales in which incidence data indicate
elevated rates of chlamydial infection among females. In addition to
screening, strategies for effective control of chlamydial infection
should include re-testing after treatment to guard against reinfec-
tion, aggressive case management, and evaluation and treatment of
sex partners [27]. Based on mathematical models of chlamydia
transmission, screening of men in addition to women [28] or
expanded partner notification [29] substantially enhance the
effectiveness of chlamydial screening on population prevalence.
While routine assessments of trends in the prevalence of
undiagnosed chlamydial infections in the general population
would be challenging, much could be learned from pilot programs
focusing on accessible subpopulations, e.g., screening secondary
school students in locales with high rates of incident STIs. In
addition, we would recommend rigorous evaluations of the impact
of expedited partner therapy, and active follow-up of patients
whose partner treatment history cannot be verified [30].
Limitations of Research
Our results should be interpreted with awareness of potential
limitations to our inferences about trends in chlamydia prevalence.
First, the 1997–98 BSBS study relied upon a ligase chain reaction
assay whereas the 2006–09 MSSP study used a transcription
mediated amplification system. The performance characteristics of
these NAAT assays are comparable and very high, and our repeat
testing of positive specimens should have theoretically increased
test specificity without affecting test sensitivity. It is not possible,
however, to dispel all uncertainty about the unavoidable non-
equivalence of methodologies. (Manufacture of the ligase chain
reaction assay was discontinued in 2003.).
Differences in survey methodologies (in-person vs. telephone
interviewing) may also have introduced non-equivalence in sample
composition. Since prevalence estimates are derived from
biospecimen testing, the difference in questionnaire administration
is not a major concern. However, the two methodologies had
varying recruitment rates (82.8% in the 1997–98 in-person survey
versus 58.7% in the 2006–09 telephone survey). While use of
poststratification weights aligns our survey samples to the
demographic distribution of the population, neither they nor
covariate adjustments employed in our statistical analyses guar-
antee sample equivalence.
We also note that the sample size for our 1997–98 survey, 335
females and 244 males, was small although statistical hypothesis
testing takes account of sample size. Larger sample sizes or a multi-
year randomized controlled trial of alternative screening policies
would certainly have produced much stronger evidence, however
these approaches were not possible given NIH funding guidelines.
Finally, we note that our results are restricted to one urban
community, Baltimore, Maryland with a relatively high rate of
(diagnosed) chlamydial infections (see Text S12). Whether these
results may be replicated in other, similar urban settings is an
important question for future research.
Nonetheless, we believe that the statistically significant divergence
in infection trends by gender should be relatively robust to the
possible effects of sample non-equivalence arising from methodo-
logical differences. While it is relatively easy to imagine scenarios in
which trends over time could arise solely from variations in survey
methodology, it is much harder to imagine conditions that would
produce a significant gender interaction in which the prevalence of
undiagnosed infection rises for men but declines for women.
Strength of Evidence
The key question – for which the evidence presented in this
article is suggestive but not determinative – is: Do estimated
changes over time represent actual changes in the population
prevalence of undiagnosed infections or could they arise as
consequences of methodological variation in study procedures
over time? We have detailed above the divergences in laboratory
assays and in survey data collection that introduce methodological
uncertainty into our inferences about changes over time in the
prevalence of undiagnosed chlamydial infections. We employed a
variety of procedures to reduce this inferential uncertainty (e.g.,
covariate controls for shifts in sociodemographic composition,
extensive multiple imputation modeling to assess the impact of
missing data, etc. Nonetheless, no such procedure can provide
inferential certainty.
Why did prevalence ‘‘increase’’ among men?. Some
readers of preliminary versions of this article wondered what
produced the ‘‘increase’’ in the prevalence of undiagnosed
infections among men. We believe a response to this question
has at least three parts. First, it should be noted that the ‘‘increase’’
in infection prevalence over the observed time period for males
was not statistically significant (p = 0.08). What was significant was
the divergence in estimated trends among males and females.
Second, our survey samples did not involve a static comparison of
the same population cohort. Cohort variation in respondent
characteristics and in initial infection prevalences (prior to
reaching eligibility age for these surveys) can produce a variety
of outcomes. Finally, given the observational nature of our data, it
is not possible to answer with certainty questions about causality.
Concluding Remarks
Overall our results demonstrate the importance of monitoring
not only diagnosed chlamydial infection but also prevalent
infection that persists, largely asymptomatic and undiagnosed, in
a population. Women account for a disproportionate percentage
of all newly acquired and diagnosed chlamydial infections in
Baltimore. The relatively stable prevalence of undiagnosed
infection among young women combined with an increase in
the number of infections diagnosed over the period 1997–98 to
2006–09 suggest that current screening practices are having only a
modest impact in reducing overall levels of infection among
women. A corresponding small increase in the incidence of
diagnosed infection and a large increase – of borderline statistical
significance – in the prevalence of undiagnosed infections among
young men suggest, however, that the burden of disease among
men has not been substantially mitigated by current screening
policies that focus exclusively on women. The potential conse-
quences of these trends on the future incidence of infection within
this population are troubling for both women and men.
We note that our results highlight the inability of surveillance
statistics on the incidence of reported STI cases to provide an
adequate picture of STI epidemiology. As the Institute of
Medicine [31] and other commentators have concluded, tracking
hidden epidemics of asymptomatic infections such as chlamydia
requires new approaches to public health surveillance. Repeated
population-based surveys using NAAT testing of self-collected
urine (or other biospecimens) provide a feasible way to study
trends in the prevalence of asymptomatic infections. These
probability surveys, coupled with analysis of reports of treated
infections, provide a new and much-needed tool for monitoring
the total burden of STIs in the population.
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Supporting Information
Figure S1 Estimated prevalence of undiagnosed chla-
mydial infections by age group and gender calcuated
from combined 1997–98 and 2006–09 surveys.
(TIF)
Table S1 Counts of chlamydia cases among 18 to 35
year old adults reported to Baltimore City Health
Department (BCHD) by gender and year, 1998 to 2009;
together with estimated size of population ages 18 to 35
and calculated rate (Cases divided by Population).
(DOCX)
Table S2 Estimates for black respondents of gender-by-
time (1997–98 vs. 2006–09) interaction using observed
survey data on chlamydia prevalence plus imputations
for missing data obtained by multiple imputation using
chained equations (MICE) procedure.
(DOCX)
Table S3 Trends in estimated prevalence of undiag-
nosed chlamydial infections among Baltimore adults by
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